Skip to content

Homoeopathy in the treatment of Progressive Myopia in children

Comparative Efficacy of Individualized Homoeopathic Medicines, Ruta Graveolans 30C and Physostigma 6C in Progressive Myopia in children: A single blind, randomized comparative trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100341
Enrollment
120
Registered
2026-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: Physostigma 6C: Four globules twice a day for the total duration of 1 year. Medicines in compliance with pharmacopoeial standards from GMP compliant manufacturers would only be used. In

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Refractive error of between minus 1 diopters to minus 5 diopters without glasses Minimum spherical equivalent (SE) to be minus 1 D (SE= sphere+1/2 cylinder)

Exclusion criteria

Exclusion criteria: Myopia related to retinal dystrophies or collagen syndromes, and developmental disorders. Children suffering from illness like Autism, Intellectual Disability, Attention Deficit Hyperactive Disorder, Congenital Cataract, Retinal detachment or Myopic macular degeneration. Children suffering from Malnutrition which will be defined as Standard deviation of less than 1 of basic metabolic index according to Z score Rashtriya Bal Swasthya Karyakaram chart for BMI chart for age 6 to 18 years (Z sccore). Participants unable to come for regular fortnightly follow up Legally authorized representative (LAR) are unable to give consent for the homoeopathic treatment.

Design outcomes

Primary

MeasureTime frame
Annual myopic progression rateTimepoint: Baseline, end of 3 months, 6 months, 9 months and 12 months

Secondary

MeasureTime frame
Axial length (AL)Timepoint: Baseline and end of 12 months;Curvature changesTimepoint: Baseline and end of 12 months;Annual axial length progression rateTimepoint: Baseline and end of 12 months

Countries

India

Contacts

Public ContactDr Renu Mittal

Central Council for Research in Homoeopathy

drdivyataneja@gmail.com9810305068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026